Eva Renee Barnett Net Worth & Insider Trades
Eva Renee Barnett - Chief Financial Officer, Immunovant, Inc
What is Eva Renee Barnett's Net Worth?
The current estimated net worth of Immunovant, Inc's Chief Financial Officer, Eva Renee Barnett, is estimated to be about $657.65K . Eva Renee Barnett owns about 268,347 units of Immunovant, Inc common stock. In the last 2 years at Immunovant, Inc, Eva Renee Barnett has sold an estimated value of $410.73K worth.
What is Eva Renee Barnett's Past Insider Trading?
Eva Renee Barnett's largest sale order was 29,959 units , worth over $217.2K on January 11, 2022. In total, Eva Renee Barnett has made about 6 transactions over 2 years of their time at Immunovant, Inc. Eva Renee Barnett usually trades in October, with the busiest year in 2022. The most recent transaction was a sale order of 4,510 units , worth over $75.52K on January 13, 2023.
Eva Renee Barnett
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Eva Renee Barnett's' Mailing Address?
- Mailing address is C/o Immunovant, Inc. 320 West 37th Street, 6th Floor New York NY 10018 NY
Immunovant, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Peter Salzmann, M.D., M.B.A. | 2020 | $ 567,000 | $ 311,850 | $ 3,252,500 | $ 11,104,950 | $ | $ 139,004 | $ 15,375,304 |
| Peter Salzmann, M.D., M.B.A. | 2019 | $361,010 | $500,000 | - | $7,721,344 | $224,480 | - | $8,806,834 |
| Pamela Yanchik Connealy, M.B.A. | 2020 | $393,000 | $157,200 | $785,400 | $4,258,363 | - | $8,742 | $5,602,705 |
| Pamela Yanchik Connealy, M.B.A. | 2019 | $147,618 | - | - | $2,437,762 | $61,233 | $129,321 | $2,775,934 |
| Julia G. Butchko, Ph.D. | 2020 | $372,000 | $148,800 | $926,500 | $6,384,856 | - | $10,201 | $7,842,357 |
| Michael J. Elliott, | 2020 | $242,425 | $96,000 | $1,659,200 | $14,229,311 | - | $9,695 | $16,236,631 |
| Rita Jain, M.D. | 2020 | $101,137 | $38,526 | $2,703,005 | $10,666,997 | - | $3,319 | $13,512,984 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1764013/000176401321000083/imvt-20210331defproxy.htm
What are Immunovant, Inc's Past Insider Trades?
Immunovant, Inc's most recent insider trade came on February 3, 2023 by William L Macias who sold 537 units worth $9.79K . In the last 3 years, insiders at Immunovant, Inc have sold an estimated value of $4.22M and bought an estimated value of $399.92M worth of shares. Insider trading is most common in August, with the busiest year in 2022. The most active traders at the company are Julia G Butchko, Chief Dev. & Tech. Officer, Peter Salzmann, Chief Executive Officer, and William L Macias, Chief Medical Officer .
Immunovant, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||